.Pharmacolibrary.Drugs.ATC.J.J02AX06 .Pharmacolibrary.Drugs.ATC.J.J02AX06| name: | Anidulafungin |
| ATC code: | J02AX06 | route: | intravenous |
| n-compartments | 2 |
Anidulafungin is an echinocandin antifungal used for the treatment of invasive candidiasis and other serious fungal infections. It inhibits glucan synthesis, a crucial component of fungal cell walls. It is approved for use in many countries, including the US and Europe.
Pharmacokinetic parameters observed in adult patients (both sexes) with invasive candidiasis after intravenous infusion.
Wasmann, RE, et al., & Brüggemann, RJ (2018). Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults. Antimicrobial agents and chemotherapy 62(7) –. DOI:10.1128/AAC.00063-18 PUBMED:https://pubmed.ncbi.nlm.nih.gov/29712664
Liu, P, et al., & Damle, B (2013). Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasis. Antimicrobial agents and chemotherapy 57(4) 1672–1676. DOI:10.1128/AAC.02139-12 PUBMED:https://pubmed.ncbi.nlm.nih.gov/23335738
Xie, R, et al., & Liu, P (2020). Population Analysis of Anidulafungin in Infants to Older Adults With Confirmed or Suspected Invasive Candidiasis. Clinical pharmacology and therapeutics 108(2) 316–325. DOI:10.1002/cpt.1831 PUBMED:https://pubmed.ncbi.nlm.nih.gov/32189334